Predict your next investment

Myelo Therapeutics company logo
HEALTHCARE | Drug Development
myelotherapeutics.com

See what CB Insights has to offer

Founded Year

2013

Stage

Series C | Alive

Total Raised

$6M

About Myelo Therapeutics

Myelo Therapeutics is a pharmaceutical company that develops innovative treatments in areas with high unmet medical needs. Its lead compound, Myelo001, is a small molecule for the treatment of patients with chemotherapy-induced neutropenia and thrombocytopenia.

Myelo Therapeutics Headquarter Location

Kastanienallee 56

Berlin, D-10119,

Germany

+49 (0)170 9126 402

Latest Myelo Therapeutics News

Global Chemotherapy Induced Thrombocytopenia Market Things to Focus on to Ensure Long-term Success | Mission Pharmacal Company, Myelo Therapeutics GmbH, Dova Pharmaceuticals, Inc. and Others.

Apr 7, 2021

Chemotherapy is the cancer treatment given to patients with different forms of the cancer. Various drugs such as alkylating agents, antimetabolites, targeted therapy, immunotherapy drugs, etc. are used for the cancer treatment. These chemotherapy agents acts against the cancerous as well as normal cells, resulting in decreased number of the cells of all types in the body. Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has causedsevere impacts on the global economy at various levels and which can be seen onthe Healthcare industry as well. The thriving market of health care researchand development is expected to exhibit a steep decline in the sales during thelockdown period owing to the shutdown of the manufacturing units, acuteshortage in the supply of raw materials and absence of potential manpower. Itcan be deduced from the current situations brought about by the pandemic thatthe production, and supply chain activities have experienced minor hurdles.However, the market is projected to gradually recover post-COVID-19, which willpresent attractive opportunities for sales across various regions of the worldin the following years. Future Market Insights (FMI) adopteda multidisciplinary approach during the pandemic-era to focus on the growth anddevelopment of the ChemotherapyInduced Thrombocytopenia Market . Thestudy features insights on the current growth dynamics and the major revenuereforms prevailing in the market as along with the key takeaways over theforecast. The team of analysts at Future MarketInsights are focussing on research and market study to produce differentChemotherapy Induced Thrombocytopenia Market forecasts and predictions at bothnational and international levels. They have considered several leads ofinformation pertaining to the industry like market figures and mergerestimations to assess and produce reliable and informative insights on theChemotherapy Induced Thrombocytopenia Market. To remain ‘ahead’ of your competitors, Ask aQuestion >> https://www.futuremarketinsights.com/ask-question/rep-gb-10417 Key Players The writer will create content on thegeneral strategies of market players. And then will write the key players inthe market are: Novartis AG, Teva Pharmaceutical Industries Ltd, Mylan N.V.,Pfizer Inc., Janssen Global Services, LLC (Johnson & Johnson), PartnerTherapeutics, Inc., Mission Pharmacal Company, Myelo Therapeutics GmbH, DovaPharmaceuticals, Inc. and Others. Segmentation The report provides insights on the important highlights and currenttrends prevailing in the market. This helps the readers to gain a deeperunderstanding and form an unbiased opinion on the market. Numeroussegmentations have been provided for this market based on: By the drug class, the globalchemotherapy induced thrombocytopenia market is segmented as: Growth Factors i.e. ThrombopoietinReceptor Agonists Thrombopoietic Agents Oral Hospital Pharmacies Fullin-depth analysis of the parent market The analysts at FMI are dedicated toprovide insights after extensive research and study. The study also includesestimations, projections and evaluation of the market dynamics. Importantchanges in market dynamics The report has beencreated after detailed and exhaustive studies by the analysts at FMI takingseveral factors into consideration like monetary, ecological, social,mechanical, and political status of a particular demography. They study the keydata to assess the revenue and production of manufacturers across variousregions. The report also covers an in-depth analysis ofthe key changes in market dynamics in the recent past and the near future. Segmentationdetails of the market Emerging segments and regional markets Queries Solved What are the key segments andsub-segments in the market? What are the key drivers, restraints,opportunities, and challenges of the Chemotherapy Induced ThrombocytopeniaMarket in the Healthcare Industry, and how they are expected to impact themarket? What are the attractive investmentopportunities within the Chemotherapy Induced Thrombocytopenia Market in theHealthcare Industry? What is the Chemotherapy InducedThrombocytopenia Market in the Healthcare Industry size at the regional andcountry-level? What are the key market playersfocusing on? What are the strategies for growthadopted by the key players in Chemotherapy Induced Thrombocytopenia Market inthe Healthcare Industry? What are the recent trends inChemotherapy Induced Thrombocytopenia Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)? What are the challenges to theChemotherapy Induced Thrombocytopenia Market in the growth of the HealthcareIndustry? What are the key market trendsimpacting the growth of the Chemotherapy Induced Thrombocytopenia Market in theHealthcare Industry? To receive extensive list of importantregions, ask for TOC here >>  https://www.futuremarketinsights.com/toc/rep-gb-10417 Table of Content MarketBackground     Reasons to Buythe report We provide authentic and detailed ananalysis on various market trends to enable businesses to make informed andbeneficial decisions to attain competitive edge over key players. Our analysts provide detailed marketsegmentation along with meaningful insights and extensive reports that othercompanies fail to include. The report includes accurate analysisof the market and the current developing trends affecting the growth. FMI speaks tostakeholders across the spectrum, including C-level executives, distributors,product manufacturers, industry experts. This ensures that the data collected is fromhighly reliable sources. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Mammalian Transient Protein Expression Market  –The mammalian transient protein expression market has reflected steady growthon the back of growing demand from the biomedicine sector. Efforts into vaccinedevelopment continue to create possibilities for new opportunities. In Vitro Fertilization Banking Services Market  –According to the Centers for Disease Control and Prevention (CDC), about 10% ofwomen in the United States between ages 15 to 44 years have infertility whilethe rate of male infertility is 4.5-6% in North America. Cryopreservation for In-vitro Fertilization (IVF) Market  –According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150 countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Myelo Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Myelo Therapeutics is included in 2 Expert Collections, including Biopharma Tech.

B

Biopharma Tech

15,532 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Myelo Therapeutics Patents

Myelo Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Cytokines
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/25/2019

Clusters of differentiation, Monoclonal antibodies, Radiation health effects, Cytokines, Immunology

Application

Application Date

9/25/2019

Grant Date

Title

Related Topics

Clusters of differentiation, Monoclonal antibodies, Radiation health effects, Cytokines, Immunology

Status

Application

Myelo Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Myelo Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.